SecBot SecBot
DEFA14A ·Filed Apr 23, 2026

DYN

Dyne Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed6mo ago SEC0001193125-26-173702
Proxy solicitation materials
Actionable Insight • Neutral

Monitor for any unexpected developments in the upcoming shareholder meeting, though this filing suggests business as usual.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$18.26
T+0 close · Apr 23, 2026 · via day close
Latest settled
+30.50%
T+60 · $23.83
Vs SPY
+25.42%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 24 $18.26entry
  2. T+1 · 7mo ago −1.20%α −1.37% · $18.04
  3. T+5 · 7mo ago −3.89%α −4.80% · $17.55
  4. T+20 · 6mo ago −4.87%α −8.90% · $17.37
  5. T+60 · 4mo ago +30.50%α +25.42% · $23.83
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Dyne Therapeutics has filed its definitive proxy statement for the upcoming annual shareholder meeting. The filing is routine and contains no material changes or unexpected events. The company is seeking shareholder approval for director elections, executive compensation, and auditor appointment.

Key Financial Metrics

Vote
director election

Key Facts

  • Routine proxy filing for annual shareholder meeting
  • No material changes or unexpected events disclosed
  • Items include director elections, executive compensation, and auditor appointment

Financial Impact

No immediate financial impact expected

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-173702
Document: 0001193125-26-173702-index-headers.html0001193125-26-173702
Document: 0001193125-26-173702-index.html0001193125-26-173702
Document: 0001193125-26-173702.txt0001193125-26-173702

Track record

54 reports on DYN

Performance horizon

12 of 16 bullish or bearish reports moved the stock their way by T+20. Best: +46.36% at T+60 after the May 20, 2026 report. 15 of 16 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $16.77 Now $16.70 −0.39% settles Dec 15
  2. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  3. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  4. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  5. Nov 5, 202611d ago Press Release Neutral 5/10 Entry $17.36 Now $16.70 −3.80% settles Dec 4
  6. Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $17.04 Now $16.70 −2.00% settles Nov 27
  7. Oct 22, 202625d ago Press Release Neutral 2/10 Entry $15.62 Now $16.70 +6.91% settles Nov 20
  8. Oct 12, 20265w ago Institutional Cluster Mixed 4/10 Entry $15.96 to $18.62 Now $16.70 +4.64% ▲ +16.67% +19.93% vs SPY
  9. Sep 29, 20266w ago Press Release Bullish 7/10 Entry $16.11 to $16.94 Now $16.70 +3.66% ▲ +5.15% +4.23% vs SPY
  10. Sep 8, 20269w ago Insider Cluster Neutral 3/10 Entry $19.19 to $15.97 Now $16.70 −12.98% ▼ −16.78% −18.72% vs SPY
Showing 10 of 54

US Market Status

Market Closed · Opens Wed (9h 43m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 23, 2026